Protara Therapeutics, Inc.

TARA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$162,798$39,586$24,127$35,724
Short-Term Investments$7,494$25,994$60,243$55,505
Receivables$0$242$486$634
Inventory$0$0$1,163$0
Other Curr. Assets$1,863$2,883$127$1,249
Total Curr. Assets$172,155$68,705$86,146$93,112
Property Plant & Equip (Net)$5,282$6,560$7,869$8,890
Goodwill$0$0$0$29,517
Intangibles$3,245$2,661$84$0
Long-Term Investments$0$0$17,886$39,467
Tax Assets$0$0$0$0
Other NC Assets$772$1,028$1,305$1,610
Total NC Assets$9,299$10,249$27,144$79,484
Other Assets$0$0$0$0
Total Assets$181,454$78,954$113,290$172,596
Liabilities
Payables$4,429$2,434$1,586$954
Short-Term Debt$1,124$983$917$855
Tax Payable$0$0$0$41
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,408$2,732$3,237$2,448
Total Curr. Liab.$10,961$6,149$5,740$4,298
LT Debt$3,359$4,484$5,467$6,384
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,359$4,484$5,467$6,384
Other Liabilities$0$0$0$0
Cap. Leases$4,483$5,467$6,384$7,239
Total Liabilities$14,320$10,633$11,207$10,682
Equity
Pref Stock$0$0$0$0
Common Stock$35$11$11$11
Retained Earnings-$244,980-$200,384-$159,964-$94,012
AOCI$2-$31-$688-$211
Other Equity$412,077$268,725$262,724$256,126
Total Equity$167,134$68,321$102,083$161,914
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$181,454$78,954$113,290$172,596
Net Debt-$158,315-$34,119-$17,743-$28,485